Dilated Cardiomyopathy

Gene: FBN1

Amber List (moderate evidence)

FBN1 (fibrillin 1, Ensemblv115)
EnsemblGeneIds (GRCh38): ENSG00000166147
EnsemblGeneIds (GRCh37): ENSG00000166147
OMIM: 134797, ClinGen, DECIPHER
FBN1 is in 24 panels

1 review

Natasha Henden (Ingles Lab, Garvan Institute of Medical Research)

I don't know

Dilated cardiomyopathy (DCM) is increasingly recognised as a primary manifestation of Marfan Syndrome (MFS) and/or FBN1 haploinsufficiency. Intrinsic cardiomyopathy characterised by left ventricular dilation and dysfunction has been observed in 13-21.7% and 16-39.8% of paediatric and adult MFS patients, respectively; with approximately 23% of these patients presenting without concomitant valvular disease, and at least 3% of adult patients (n=3 of 97 adult MFS patients from the GenTAC registry) presenting with ventricular only and not aortic dilation (PMID: 39900832, PMID: 24531548).

Additionally, fibrillin-1 haploinsufficiency murine models manifest primary DCM due to abnormal mechano-signalling in cardiomyocytes. Observation of increased angiotensin II receptor signalling and reduced focal adhesion kinase activity indicates chronic mechanical stress in cardiomyocytes drives DCM presentation and progression, in otherwise phenotypically normal fibrillin-1-deficient mice (PMID: 24531548).
Sources: Literature
Created: 18 Jun 2026, 12:09 p.m.

Mode of inheritance
MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted

Phenotypes
MONDO:0005021 Dilated Cardiomyopathy; MONDO:0007947 Marfan Syndrome; MONDO:0019625 Familial Thoracic Aortic Aneurysm and Aortic Dissection

Publications

History Filter Activity

Note: This information shows the history of the gene symbol, not the gene entity. Where the gene symbol for a gene has changed, this history may reference a different gene to the entry you are currently viewing.
18 Jun 2026, Gel status: 2

Entity classified by Genomics England curator

Zornitza Stark (Victorian Clinical Genetics Services)

Gene: fbn1 has been classified as Amber List (Moderate Evidence).

18 Jun 2026, Gel status: 2

Set Phenotypes

Zornitza Stark (Victorian Clinical Genetics Services)

Phenotypes for gene: FBN1 were changed from MONDO:0005021 Dilated Cardiomyopathy; MONDO:0007947 Marfan Syndrome; MONDO:0019625 Familial Thoracic Aortic Aneurysm and Aortic Dissection to MONDO:0007947 Marfan Syndrome

18 Jun 2026, Gel status: 2

Entity classified by Genomics England curator

Zornitza Stark (Victorian Clinical Genetics Services)

Gene: fbn1 has been classified as Amber List (Moderate Evidence).

18 Jun 2026, Gel status: 0

Created, Added New Source, Set mode of inheritance, Set publications, Set Phenotypes

Natasha Henden (Ingles Lab, Garvan Institute of Medical Research)

gene: FBN1 was added gene: FBN1 was added to Dilated Cardiomyopathy. Sources: Literature Mode of inheritance for gene: FBN1 was set to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted Publications for gene: FBN1 were set to PMID: 39900832; 24531548 Phenotypes for gene: FBN1 were set to MONDO:0005021 Dilated Cardiomyopathy; MONDO:0007947 Marfan Syndrome; MONDO:0019625 Familial Thoracic Aortic Aneurysm and Aortic Dissection Review for gene: FBN1 was set to AMBER